A lot of people in Howard County spend months sometimes years researching ketamine therapy before they ever pick up the phone to ask about it. They’ve read the studies. They’ve talked to their doctor. They’ve watched someone they know get their life back after treatment. And still, the first question that stops most of them cold is the same one: Can I actually afford this?
The assumption that advanced psychiatric treatment is financially out of reach keeps a lot of people stuck when relief was closer than they realized. So before anything else, let’s be direct: if you’re asking specifically about IV ketamine infusions, most insurance plans do not cover them. That’s not a gray area, and we’re not going to suggest otherwise.
But that is not the end of the story not by a long way. For patients in Columbia, MD who need coverage, there are two clinically proven, FDA-approved treatment paths that most major insurance plans do cover. Both are offered at The Mood Center. Understanding the distinction between what’s covered and what isn’t is what makes the difference between staying stuck and starting treatment.
Why IV Ketamine Isn’t Covered and Why That’s a Reasonable Policy Position
Ketamine has been used in medicine for decades, first as a surgical anesthetic and more recently as one of the most effective treatments available for conditions like treatment-resistant depression, PTSD, and chronic pain. The problem from an insurance standpoint is that using IV ketamine for psychiatric conditions is what’s known as off-label prescribing.
“Off-label” means a medication is being used for a purpose that doesn’t have its own specific FDA approval. The practice is legal and common physicians make off-label prescribing decisions regularly based on clinical evidence. But insurance companies generally will not reimburse treatments they haven’t reviewed and classified as medically necessary for a defined indication. IV ketamine for psychiatric use hasn’t cleared that bar with most insurers, and so it remains a self-pay treatment at the majority of clinics nationwide, including at The Mood Center.
This isn’t a failing of the treatment itself, which has decades of evidence behind it. It’s a coverage policy gap, and it’s a genuine frustration for patients and providers alike. What changed the equation is what happened next.
SPRAVATO® (Esketamine): FDA-Approved and Covered by Insurance
In 2019, the FDA approved SPRAVATO® (esketamine nasal spray) specifically for adults with treatment-resistant depression defined as patients who have not responded adequately to at least two antidepressant medications. A second approval followed in 2020 for major depressive disorder with acute suicidal ideation or behavior. These are not off-label uses. SPRAVATO® has dedicated FDA approval for these psychiatric indications, which means insurers can no longer classify it as experimental or investigational.
Research published in the New England Journal of Medicine (2019) demonstrated significant and rapid symptom reduction in adults with treatment-resistant depression using esketamine the same clinical evidence base that drove FDA approval and opened the door to insurance coverage.
For patients in Columbia whose insurance includes CareFirst, Anthem, Aetna, Cigna, UnitedHealthcare, Tricare, Maryland Medicaid, or Medicare, SPRAVATO® is very likely to be a covered benefit. Deductibles, co-pays, and prior authorization requirements vary by plan, but the foundational question of eligibility has already been resolved in the patient’s favor. That is a meaningfully different starting point than IV ketamine.
Medicare coverage for SPRAVATO® deserves particular attention. Patients over 65 or those on Medicare due to disability have historically had the fewest options when it comes to advanced psychiatric treatments. SPRAVATO® changed that. The Mood Center accepts Medicare at its Columbia location, and SPRAVATO® is a covered Medicare benefit for qualifying patients.
TMS Therapy: Another Covered Path for the Right Patient
SPRAVATO® isn’t the only covered option. Transcranial Magnetic Stimulation (TMS) a non-invasive, drug-free treatment that uses targeted magnetic pulses to stimulate areas of the brain involved in mood regulation is FDA-approved for major depressive disorder and OCD, and is covered by most major insurance plans including all eight carriers The Mood Center accepts in Columbia.
TMS requires no IV, no sedation, and no time off work. Sessions typically run 20 to 30 minutes, and patients can drive themselves home afterward. For patients who have not responded to antidepressants and prefer a treatment that involves no medication at all, TMS is often the most practical covered option available.
The clinical case for TMS is well established. A landmark study published in Brain Stimulation (2018) found that more than half of patients with treatment-resistant depression achieved meaningful clinical response through TMS therapy, with a substantial number achieving full remission.
When SPRAVATO® and TMS are both in the picture, most Columbia patients who have been through the antidepressant cycle without lasting success will qualify for at least one covered treatment path often both.
Which Insurance Plans Does The Mood Center Accept in Columbia?
The Mood Center’s Columbia location at 11055 Little Patuxent Parkway is in-network with CareFirst, Anthem, Aetna, Cigna, UnitedHealthcare, Tricare, Maryland Medicaid, and Medicare. For a clinic offering this level of interventional psychiatry, that is an unusually broad network and it’s one of the most meaningful ways The Mood Center stands apart from other providers in the region.
Being in-network means your insurer has pre-negotiated rates with the clinic, which typically results in significantly lower out-of-pocket costs than going out of network. For SPRAVATO® and TMS patients, in-network status reduces what you pay per session to a co-pay or cost-sharing amount rather than the full price of treatment.
If IV ketamine is the treatment you specifically want to pursue, it is available at The Mood Center as a self-pay service. Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) can be applied toward the cost as qualifying medical expenses. Our team is glad to discuss pricing and answer questions during your consultation.
Prior Authorization: What to Expect
Even when a treatment is covered, insurance plans typically require prior authorization before they’ll approve payment. For SPRAVATO® and TMS, this means your provider submits documentation diagnosis codes, treatment history, and evidence that prior antidepressant trials didn’t produce adequate results and the insurer reviews the case before issuing approval.
For SPRAVATO®, the standard threshold is two or more antidepressant trials without sufficient response. Most people considering ketamine-based treatment have already exceeded that threshold by a wide margin. Meeting the prior authorization criteria tends to be more straightforward than patients anticipate when they first hear the term.
TMS prior authorization works similarly. The Mood Center’s clinical team handles this process regularly and can walk Columbia patients through what documentation is needed and what the timeline looks like for their specific insurer.
The Mood Center Handles the Insurance Process for You
All you need is your insurance card. When you call The Mood Center’s Columbia team, our patient care coordinators take it from there verifying your benefits, confirming in-network status, and working through prior authorization on your behalf before your first appointment. No phone trees with your insurer. No trying to decode whether SPRAVATO® falls under your mental health benefit or your pharmacy benefit. Just one call to us, and we’ll give you a clear picture of what your plan covers and what to expect financially before you ever commit to anything.
Don’t Let Cost Be the Reason You Keep Waiting
For patients with treatment-resistant depression, PTSD, or OCD, the cost of continued inaction is real. A 2021 analysis in Psychiatric Services found that treatment-resistant depression carries substantially higher rates of healthcare utilization, hospitalization, and lost productivity than depression that responds to first-line treatment reinforcing that effective care sooner is better for patients and less costly in every direction.
Research on esketamine published in the Journal of Clinical Psychiatry (2020) found that patients who received esketamine nasal spray showed meaningful reductions in depressive symptoms, with many achieving remission after years of failed antidepressant trials.
If you’ve been sitting on the idea of treatment because you assumed you couldn’t afford it, the conversation is worth having. A covered path to care may already exist under your current plan.
Talk to Someone at The Mood Center Today
The Mood Center’s Columbia location is at 11055 Little Patuxent Parkway, Suite 209, Columbia, MD 21044, with a clinical team specializing in SPRAVATO®, TMS, and ketamine therapy for treatment-resistant depression, PTSD, OCD, and chronic pain. We’re in-network with most major insurance plans and happy to help you understand your benefits before you ever walk through the door.
To schedule a free consultation or ask about your coverage, call us at 443-940-MOOD or visit themoodcenter.com/schedule-form.
Elevate Your Mood starting with finding out what’s possible.
The information in this article is intended for educational purposes only and does not constitute medical advice. Please consult a qualified healthcare provider to discuss your specific situation and treatment options.
